AstraZeneca Pharma India Limited (NSE:ASTRAZEN)
India · Delayed Price · Currency is INR 8,050.00
+26.50 (0.33%)
Jul 20, 2026, 3:29 PM IST
AstraZeneca Pharma India Market Cap
AstraZeneca Pharma India has a market cap or net worth of 201.59 billion as of July 20, 2026. Its market cap has decreased by -11.49% in one year.
Market Cap
201.59B
Enterprise Value
198.21B
Revenue
22.76B
Ranking
n/a
PE Ratio
107.50
Stock Price
8,050.00
ChartMarket Cap Chart
Since February 27, 2002, AstraZeneca Pharma India's market cap has increased from 1.45B to 201.59B, an increase of 13,802.76%. That is a compound annual growth rate of 22.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 201.59B | -10.50% |
| Dec 31, 2025 | 225.25B | 23.26% |
| Dec 31, 2024 | 182.75B | 32.43% |
| Dec 29, 2023 | 138.00B | 67.65% |
| Dec 30, 2022 | 82.31B | 6.20% |
| Dec 31, 2021 | 77.51B | -32.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gland Pharma | 403.49B |
| Emcure Pharmaceuticals | 341.77B |
| Wockhardt | 304.90B |
| Piramal Pharma | 238.12B |
| Eris Lifesciences | 201.67B |
| NATCO Pharma | 173.06B |
| Cohance Lifesciences | 169.06B |
| Alembic Pharmaceuticals | 162.18B |